Ophthalmology

Doç. Dr. Aslan Aykut

Doctor and researcher Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi İstanbul
Macular EdemaDiabetic RetinopathyRetinopathy of PrematurityDiabetes MellitusIntellectual Disability
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Macular Edema 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Diabetic Retinopathy 7 publications
  • Retinopathy of Prematurity 2 publications
  • Diabetes Mellitus 2 publications
  • Intellectual Disability 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyOphthalmologysaglik.gov.trFrom source
  • InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workMacular EdemaExtracted from 8 publications · Model version —From source
  • Publications60 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-5426-1992ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1395204/doktorlarimiz.html#aslan-aykutsaglik.gov.tr

Scientific work

Publications on Macular Edema

60 publications

  1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261480211 PMID 42630057 Open-access full textSource: OpenAlex

  2. Long‐Term Peripheral Vitreoretinal Interface Abnormalities of Retinopathy of Prematurity: Ultra‐Wide Field Optical Coherence Tomography Findings

    Clinical & Experimental Ophthalmology, 2026

    DOI 10.1111/ceo.70106 PMID 41846489 Source: ORCID

  3. Diagnostic Utility of Peripheral Blood MYD88 L265P Testing in Vitreoretinal Lymphoma

    Genes, 2026

    DOI 10.3390/genes17101172 PMID 42938287 Open-access full textSource: ORCID

  4. Comparison of Optical Coherence Tomography Biomarkers in Nonproliferative and Proliferative Diabetic Retinopathy: Marmasia Study Group Report No. 2

    Turkish journal of ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.24196 PMID 42928578 Open-access full textSource: Europe PMC

  5. Multimodal Imaging Features of Bilateral Diffuse Uveal Melanocytic Proliferation: A Systematic Review of 82 Patients

    Ocular Oncology and Pathology, 2026

    DOI 10.1159/000550536 PMID 41835104 Open-access full textSource: OpenAlex

  6. Does ‘Turkish ophthalmology’ need clarification? What truly constitutes our field?

    European eye research, 2026

    DOI 10.14744/eer.2025.57441 Open-access full textSource: OpenAlex

  7. Reply

    Retina, 2026

    DOI 10.1097/iae.0000000000004890 PMID 42212945 Source: OpenAlex

  8. Intravitreal nintedanib attenuates proliferative vitreoretinopathy in a mouse model: Efficacy, safety, and mechanistic insights

    Experimental Eye Research, 2026

    DOI 10.1016/j.exer.2026.111115 PMID 42264059 Source: OpenAlex

  9. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

    Eye, 2025

    DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  10. Incontinentia Pigmenti: Ocular Genetic Studies

    Güncel Retina Dergisi (Current Retina Journal), 2025

    DOI 10.37783/crj-0519 Open-access full textSource: ORCID

View all 60 publications